Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of adalimumab 80 mg weekly in luminal Crohn's disease.
Bouguen G, Laharie D, Nancey S, Hebuterne X, Flourie B, Filippi J, Roblin X, Trang C, Bourreille A, Babouri A, Bretagne JF, Siproudhis L, Peyrin-Biroulet L. Bouguen G, et al. Among authors: roblin x. Inflamm Bowel Dis. 2015 May;21(5):1047-53. doi: 10.1097/MIB.0000000000000359. Inflamm Bowel Dis. 2015. PMID: 25803504
Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.
Daniel F, Loriot MA, Seksik P, Cosnes J, Gornet JM, Lémann M, Fein F, Vernier-Massouille G, De Vos M, Boureille A, Treton X, Flourié B, Roblin X, Louis E, Zerbib F, Beaune P, Marteau P. Daniel F, et al. Among authors: roblin x. Inflamm Bowel Dis. 2007 Jan;13(1):19-23. doi: 10.1002/ibd.20046. Inflamm Bowel Dis. 2007. PMID: 17206635 Free article.
Coffee and diabetes: is homocysteine the missing link?
Peyrin-Biroulet L, Guéant JL, Roblin X. Peyrin-Biroulet L, et al. Among authors: roblin x. Arch Intern Med. 2007 Jan 22;167(2):204; author reply 205. doi: 10.1001/archinte.167.2.204-a. Arch Intern Med. 2007. PMID: 17242324 No abstract available.
Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience.
Oussalah A, Laclotte C, Chevaux JB, Bensenane M, Babouri A, Serre AA, Boucekkine T, Roblin X, Bigard MA, Peyrin-Biroulet L. Oussalah A, et al. Among authors: roblin x. Aliment Pharmacol Ther. 2008 Oct 15;28(8):966-72. doi: 10.1111/j.1365-2036.2008.03811.x. Epub 2008 Jul 24. Aliment Pharmacol Ther. 2008. PMID: 18652603 Clinical Trial.
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression.
Peyrin-Biroulet L, Cadranel JF, Nousbaum JB, Oussalah A, Seddik M, Canva V, Cortot A, Sogni P, Gueant JL, Bigard MA, Roblin X, Bronowicki JP. Peyrin-Biroulet L, et al. Among authors: roblin x. Aliment Pharmacol Ther. 2008 Oct 15;28(8):984-93. doi: 10.1111/j.1365-2036.2008.03812.x. Epub 2008 Jul 24. Aliment Pharmacol Ther. 2008. PMID: 18657132
A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
Roblin X, Peyrin-Biroulet L, Phelip JM, Nancey S, Flourie B. Roblin X, et al. Am J Gastroenterol. 2008 Dec;103(12):3115-22. doi: 10.1111/j.1572-0241.2008.01743.x. Am J Gastroenterol. 2008. Retraction in: Am J Gastroenterol. 2009 Mar;104(3):801. doi: 10.1038/ajg.2009.101 PMID: 19086961 Retracted. Clinical Trial.
"Comment on a retraction": author response.
Roblin X, Peyrin-Biroulet L, Phélip JM, Nancey S, Flourié B. Roblin X, et al. Am J Gastroenterol. 2009 Jul;104(7):1864-5. doi: 10.1038/ajg.2009.351. Am J Gastroenterol. 2009. PMID: 19574985 No abstract available.
352 results